Acadia Pharmaceuticals | Marktkapitalisierung

Market Capitalization Veränderung Datum
Acadia Pharmaceuticals USD 5.14B 1.73B 2023-12
ALKERMES USD 4.63B 36M 2023-12
Alnylam Pharmaceuticals USD 24.02B 1.88B 2023-12
Corcept Therapeutics USD 3.35B 554M 2023-12
Cytokinetics USD 8.19B 5.36B 2023-12
Eisai JPY 2.09T 376.18B 2023-12
Eli Lilly USD 731.69B 178.32B 2024-03
Incyte USD 12.89B 1.18B 2024-03
Intra Cellular Therapies USD 6.67B 227M 2024-03
Moderna USD 40.08B 2.16B 2024-03
Neurocrine Biosciences USD 14.28B 1.33B 2024-03
Pfizer USD 155.51B 7.05B 2024-03
PTC Therapeutics USD 2.22B 145M 2024-03
Sarepta Therapeutics USD 11.76B 2.73B 2024-03
Ultragenyx Pharmaceutical USD 3.77B 153M 2024-03
Vertex Pharmaceuticals USD 106.53B 1.68B 2024-03



Acadia Pharmaceuticals Marktkapitalisierung - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2024.